Some clinical potentials of chlorophenoxyisobutyrate (clofibrate) therapy (hyperlipidemia--angina pectoris--blood sludging-diabetic neuropathy).
D000092:Acetohexamide / Q000627:therapeutic use; D000328:Adult; D000371:Agglutination / Q000187:drug effects*; D000787:Angina Pectoris / Q000188:drug therapy*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy*; D001835:Body Weight; D002087:Butyrates / Q000627:therapeutic use*; D002747:Chlorpropamide / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D003228:Conjunctiva / Q000098:blood supply; D048909:Diabetes Complications; D003929:Diabetic Neuropathies / Q000188:drug therapy; D004038:Diet, Reducing; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D006949:Hyperlipidemias / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010629:Phenformin / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood; D014859:Warfarin / Q000009:adverse effects; D014973:Xanthomatosis / Q000188:drug therapy
D000924:Anticholesteremic Agents; D002087:Butyrates; D014280:Triglycerides; D014859:Warfarin; D002784:Cholesterol; D010629:Phenformin; D000092:Acetohexamide; D002747:Chlorpropamide